Biological Sciences Division
Published July 14, 2021 | Version v1
Journal article Open

COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity

Creators

  • 1. Insilico Medicine
  • 2. Intel Corporation
  • 3. University of New Mexico
  • 4. University of Chicago

Description

Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we introduce COVIDomic, a multi-omics online platform designed to facilitate the analysis and interpretation of the large amount of health data collected from patients with COVID-19. The COVIDomic platform provides a comprehensive set of bioinformatic tools for the multi-modal metatranscriptomic data analysis of COVID-19 patients to determine the origin of the coronavirus strain and the expected severity of the disease. An integrative analytical workflow, which includes microbial pathogens community analysis, COVID-19 genetic epidemiology and patient stratification, allows to analyze the presence of the most common microbial organisms, their antibiotic resistance, the severity of the infection and the set of the most probable geographical locations from which the studied strain could have originated. The online platform integrates a user friendly interface which allows easy visualization of the results. We envision this tool will not only have immediate implications for management of the ongoing COVID-19 pandemic, but will also improve our readiness to respond to other infectious outbreaks.

Data availability

The data underlying the results presented in this study are available from "Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa203". The data were downloaded from the Genome Warehouse in National Genomics Data Center, (project number PRJCA002202) publicly accessible at https://bigd.big.ac.cn/gsa.

Files

journal.pcbi.1009183.pdf

Files (3.4 MB)

Name Size Download all
Article
md5:971e477e22eddff7de980435c46def4c
3.2 MB Preview Download
Figure
md5:22b8a91ad91a91cd21bf19423cbaec80
235.8 kB Preview Download
md5:95a10422a33e50581b364b2ca98fb06f
18.8 kB Download

Additional details

Identifiers

DOI
10.1371/journal.pcbi.1009183
Other
oai:uchicago.tind.io:5947

Funding

Intel Corporation

UChicago Information

Division(s)
Biological Sciences Division, Pritzker School of Molecular Engineering
Department(s)
Medicine, Surgery